Omission of chemotherapy for low-grade, luminal A N1 breast cancer: Patterns of care and clinical outcomes

Using CT for Luminal A N1 breast cancer is decreasing over time, primarily in older patients and at academic centers. Although CT is still associated with an OS advantage in all patients, subgroup analysis demonstrated no OS benefit in women >50 years of age. These results have implications on the ongoing randomized trials.